MHE Staff

The Pharmacy partnership program with nursing homes and assisted living facilities has benefited patients most vulnerable to COVID-19 with the vaccine rollout. The American Health Care Association and National Center for Assisted Living claim, so far, things are going ok.

In this final part of a six-part series, most are neutral-to-negative on chance of meaningful change.

How the pandemic has accelerated innovation, and how CVS Health is preparing to delivery vaccines for COVID-19.

In this fifth part of a six-part series, data said respondents split on the effect of the pandemic on value-based care

In this fourth part of a six-part series, data shows the pandemic severely affected revenues, expenses.

In this third of a six-part series, respondents give administration poor marks.

In this second of a six-part series, the biggest concern is short supply.

Respondents ranked the importance of healthcare issues.

The second mRNA vaccine, which does not need the extreme refrigeration of the Pfizer product, began rolling out of a warehouse in Mississippi early Sunday. Friday brought other late-year approvals in cancer treatment.

Pfizer's other vaccine news of the week involves pneumococcal disease.

A filing for a bispecific antibody, and more time after a therapy gets more responses.

The subsidiary, called Vivid Clear Rx, will provide PBM services to help the company's 88,000 employees better manage their healthcare costs.

CVS and Walgreens are poised to vaccinate residents and employees of long-term care facilities. Dentists and optometrists are angling to be among the healthcare professionals who could administer the COVID-19 vaccines.

Nearly two-thirds of U.S. patients are likely to switch to a new healthcare provider if their current health provider doesn’t meet their expectations for managing COVID-19 concerns.

FDA approves several drugs to treat rare conditions in both cancer and metabolic diseases.

Radiation oncologists across the country met virtually with members of Congress last week to urge lawmakers to pass legislation that will safeguard access to high-quality, value-based healthcare for people with cancer.

COVID-19 has amplified the growing importance of advanced practice providers as demands for healthcare increase and a national physician shortage looms.

If Pfizer's vaccine gets an emergency use authorization, it could reach sites designated by states within a day.

Updates from the American Heart Association Scientific Sessions.

Manufacturing issue creates setback for Alkermes on much-anticipated therapy that mitigates weight gain.

A Cleveland Clinic scientist stopped short of saying doctors should take patients off Vascepa, but he said he has questions due to the lack of a "neutral comparator."

The findings are the first in a series of six studies involving a registry supported by drug makers in the diabetes, cardiovascular, and heart failure space.

DocASAP’s second annual survey reveals an accelerated demand for timely, convenient care across different settings and the pandemic’s impact on care.

Starting this week, the editors of Managed Healthcare Executive® are launching a new, twice-a-month podcast about how those barriers can removed, lowered, or worked around so all patients get the healthcare they need.

Pandemic prompts supply chain to focus on reducing risk, building resilience; concerns remain about data accuracy.

Vivek Murthy, M.D., MBA, former surgeon general, David Kessler, M.D., former FDA commissioner, and Marcella Nunez-Smith, M.D., M.H.S., an associate professor at Yale Medical School are the co-chairs

University of Vermont researchers say their data show there are alternative approaches to using gadolinium-based contrast agents in follow-up MRIs of patients with multiple sclerosis.

A survey by Luma Health shows that 52% of patients are comfortable or very comfortable with telehealth. A quarter of providers see a risk of their organizations going out of business.

Forty-three percent of new cases in nursing homes are coming from midwest states.